Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 11/20 | 0.43 |
| ▸ | NR1H3 | Q13133 | 11/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.40 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.40 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19089865 | 0.84 | NPC1 (0.41) | NR1H2NR1H3ALDH3A1ALDH1A3KDM4E | |
| SCHEMBL17660031 | 0.84 | CNR2 (0.39) | NR1H2NR1H3NR1I2ALDH3A1ALDH1A3 | |
| SCHEMBL2950543 | 0.81 | CRHR1 (0.42) | NR1H2NR1H3NR1I2EGFRERBB2 | |
| SCHEMBL10776318 | 0.79 | S1PR1 (0.48) | NR1H2NR1H3NR1I2EGFRERBB2 | |
| SCHEMBL12304302 | 0.79 | ALDH3A1 (0.45) | NR1H2NR1H3NR1I2ALDH3A1ALDH1A3 | |
| SCHEMBL2014159 | 0.78 | EGFR (0.47) | NR1H2NR1H3EGFRERBB2KDM4E | |
| SCHEMBL17663681 | 0.78 | EGFR (0.47) | NR1H2NR1H3EGFRERBB2KDM4E | |
| SCHEMBL768272 | 0.78 | EGFR (0.47) | NR1H2NR1H3EGFRERBB2KDM4E | |
| SCHEMBL7153351 | 0.78 | EGFR (0.50) | NR1H2NR1H3EGFRERBB2ALDH3A1 | |
| SCHEMBL2950313 | 0.78 | SLC16A3 (0.48) | NR1H2NR1H3NR1I2EGFRERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7759504-B2 | Diimmonium compound having perchlorate ion or hexafluorophosphate ion as counter ion with sufficient heat resistance and solubility; photopolymerization initiator and electrophotographic photoreceptor | FUJIFILM CORPORATION (JP) | 2010-07-20 | — | — | US | disclosed |
| US-20080255387-A1 | TRIARYLAMINE DERIVATIVE | FUJIFILM CORPORATION (JP) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255387-A1 | TRIARYLAMINE DERIVATIVE | METTL14, MYH14, TOMM22 | NR1H2 911/4885NR1H3 753/4885NR1I2 191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.